Richtlijn 'Cardiovasculair risicomanagement'

- The aim of the clinical practice guideline ‘Cardiovascular risk management’ is an integral approach to all relevant risk factors for cardiovascular disease (CVD) caused by atherothrombosis.

- Patients with CVD, diabetes mellitus type 2 (DM2), elevated blood pressure or cholesterol, men of 50 years or older who smoke and women of 55 years or older who smoke are eligible for assessment of relevant risk factors for CVD.

- All high-risk patients should receive lifestyle counselling.

- In patients with CVD the use of acetylsalicylic acid and often, depending on the specific disease, a beta-blocker or an angiotensin converting enzyme (ACE) inhibitor are recommended. The use of a statin is recommended if the LDL-cholesterol concentration is ≥ 2.5 mmol/l.

- In patients with DM2, the use of statins is recommended if LDL-cholesterol is ≥ 2.5 mmol/l and use of a blood pressure lowering drug with a systolic blood pressure ≥ 140 mmHg, as well as glucose lowering drugs.

- In patients without CVD and DM2, the need for drug treatment will be determined by estimation of the absolute 10-year mortality risk of CVD. Treatment is recommended if this risk exceeds 10.

- The treatment and follow-up plan will be determined individually, depending on the risk profile, morbidity, comorbidity and patient’s preferences.

Ned Tijdschr Geneeskd. 2007;151:1068-74